Advertisement

Journal of Commercial Biotechnology

, Volume 17, Issue 4, pp 289–289 | Cite as

Exciting changes

  • Yali Friedman
Editorial
  • 953 Downloads

I am thrilled to share this exciting news with you.

After 4 years of serving as Managing Editor of the Journal of Commercial Biotechnology (JCB), I have acquired the journal and will be publishing it starting with Volume 18, Number 1, in January 2012. The JCB complements my portfolio of books and websites on the business of biotechnology built over the past decade, and this synergistic combination will enable me to substantially advance the JCB.

In short, the impact of this change in ownership will be more of the same high-quality publication you are familiar with. The staff at Palgrave Macmillan have been very supportive in preparation for the transition, and I look forward to continuing the legacy I have built under their auspices.

I have made the following near-term improvements to the JCB:
  • Associate editors have been recruited to help share the editorial load as I take on more of the publishing responsibilities. This will improve the breadth and quality of submissions and published papers.

  • A new cover design and interior template have been commissioned.

  • The JCB interior pages will now be printed in full color.

  • The new JCB website will track Internet references to posted articles and will facilitate reader commentary and discussion on individual article web pages.

  • The archives have been extended back to 2001, and I will further extend these back to Volume 1, which was published in 1994.

I would also like to take this opportunity to express my gratitude for the support of my readers, contributors, editorial board members and other reviewers. I encourage you to visit the new JCB website at CommercialBiotechnology.com.

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2011

Authors and Affiliations

  • Yali Friedman
    • 1
  1. 1.Managing Editor

Personalised recommendations